Biobank sustainability: current status and future prospects

Doucet, Marika; Yuille, Martin; Georghiou, Luke; Dagher, Georges

doi:10.2147/bsam.s100899

Cited by 35 publications

(21 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, sustaining the operations of biobanks financially, operationally, and socially requires flexible solutions over time, based on the type of unit established. [9][10][11][12] Underlying the operations of a modern and professionalized biobank is the need for strong business practices, with business planning at its core. Our global survey suggests that organizations that support biobanks have increasingly recognized the need to professionalize their management, staffing, and operations.…”

Section: Discussionmentioning

confidence: 99%

Advancing Professionalization of Biobank Business Operations: A Worldwide Survey

Henderson

Goldring

Simeon-Dubach³

2019

Biopreservation and Biobanking

View full text Add to dashboard Cite

Quality specimens from biobanks are key resources to support reproducible research. Sustaining biobanks requires robust management. We recently published a pilot survey that indicated that over half the participating biobanks had business plans in place and another third were working on business planning. While the results provided a clue to the status of business planning in biobanking, it was concluded that a longer and more indepth survey and analysis were required. In April 2017, an extended survey was distributed worldwide in English, French, Chinese, German, and Spanish, through multiple channels. The survey was built using the Survey Monkey tool. Our hypothesis was that those biobanks that already have a business plan also have a more professional management structure. The questions were designed to understand more details about each biobank's business operations and communications. A total of 276 biobanks participated (China 65, France 40, United States 34, Spain 27, Germany 24, Australia 23, and rest of the world 63). About two thirds of the biobanks were established in the last 10 years. The responses provided data on the size of biobanks answering the survey, their status of business planning, and how and through what mediums they are communicating with customers. Biobanks with a business plan or preparing to have one showed a clear trend of having a customer strategy for marketing the samples and communicating with customers. No trend could be seen regarding websites and activities in social media. We confirmed our hypothesis that biobanks that have or are in the process of preparing a business plan are showing a trend toward more professional structures. In the biobanking community, the business mind-set and use of the business plan as a management tool have not quite arrived.

show abstract

Section: Discussionmentioning

confidence: 99%

Advancing Professionalization of Biobank Business Operations: A Worldwide Survey

Henderson

Goldring

Simeon-Dubach³

2019

Biopreservation and Biobanking

View full text Add to dashboard Cite

show abstract

“…As a result, biobanks are expected to be repositioned from Mertonian functionalism (for the good of society as a whole) to agency-based frameworks that focus on performance-related processes (120). Biobanking will become increasingly embedded in health care systems that use longitudinal samples from individuals as part of their personal care and will favor translational research, aiming to bring products and therapies quickly to market (121,122).…”

Section: Consolidated Biobankingmentioning

confidence: 99%

Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies

et al. 2020

View full text Add to dashboard Cite

SUMMARY Clinical microbiology is experiencing revolutionary advances in the deployment of molecular, genome sequencing-based, and mass spectrometry-driven detection, identification, and characterization assays. Laboratory automation and the linkage of information systems for big(ger) data management, including artificial intelligence (AI) approaches, also are being introduced. The initial optimism associated with these developments has now entered a more reality-driven phase of reflection on the significant challenges, complexities, and health care benefits posed by these innovations. With this in mind, the ongoing process of clinical laboratory consolidation, covering large geographical regions, represents an opportunity for the efficient and cost-effective introduction of new laboratory technologies and improvements in translational research and development. This will further define and generate the mandatory infrastructure used in validation and implementation of newer high-throughput diagnostic approaches. Effective, structured access to large numbers of well-documented biobanked biological materials from networked laboratories will release countless opportunities for clinical and scientific infectious disease research and will generate positive health care impacts. We describe why consolidation of clinical microbiology laboratories will generate quality benefits for many, if not most, aspects of the services separate institutions already provided individually. We also define the important role of innovative and large-scale diagnostic platforms. Such platforms lend themselves particularly well to computational (AI)-driven genomics and bioinformatics applications. These and other diagnostic innovations will allow for better infectious disease detection, surveillance, and prevention with novel translational research and optimized (diagnostic) product and service development opportunities as key results.

show abstract

“…However, the potential variability in processes has a potential negative influence on the comparability and sustainability of biobanks, in particular COVID-19 biobanks. 11,12,[66][67][68][69] When the pandemic wanes or vaccination is widely available, many biobanks will likely have stored large amounts of samples and data for which there may be a reduced need and demand. Making collections visible through marketing within and outside of organizations will increase the potential for their sustainability.…”

Section: Sustainability Of Biobanksmentioning

confidence: 99%

Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond

Simeon-Dubach¹,

Henderson

2020

Biopreservation and Biobanking

View full text Add to dashboard Cite

The SARS-CoV-2 pandemic, which caused a global outbreak of COVID-19 disease, has been a crisis of extraordinary proportions, causing serious impacts for research and public health. Biobanks have played a key important role in understanding the disease and response. In our article we will highlight the opportunities and risks of biobanks during and after the pandemic. The different aspects of safety and sustainability have and will be the main challenges for biobanks. Furthermore, the role of biobanks in biomedical research and public health has been emphasized as well as opportunities that have arisen for their participation in research.

show abstract

Biobank sustainability: current status and future prospects

Cited by 35 publications

References 34 publications

Advancing Professionalization of Biobank Business Operations: A Worldwide Survey

Advancing Professionalization of Biobank Business Operations: A Worldwide Survey

Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies

Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond

Contact Info

Product

Resources

About